收藏切换
Research progress on the regulation of major signaling pathways in hyperlipidemia by traditional Chinese medicine compound formulas
收藏切换
Jingchao LI1, Jianjun CHEN2a, Wei JIA2b, Guanchun HUA2c, Li MI2c, *
World Clinical Drug | 2026, 47(7) : 802 - 809
Less
收藏切换
World Clinical Drug | 2026, 47(7): 802-809
• Review •
Research progress on the regulation of major signaling pathways in hyperlipidemia by traditional Chinese medicine compound formulas
Full
Jingchao LI1, Jianjun CHEN2a, Wei JIA2b, Guanchun HUA2c, Li MI2c, *
Affiliations
  • 1.Department of Pharmacy, Hainan Corps Hospital of the Chinese People's Armed Police Force, Haikou 202763, Hainan Province, China
  • 2a.Dean's Office, Shanghai Corps Hospital of Chinese People's Armed Police, Shanghai 201103, China
  • 2b.Department of Health and Epidemic Prevention, Shanghai Corps Hospital of Chinese People's Armed Police, Shanghai 201103, China
  • 2c.Department of Pharmacy, Shanghai Corps Hospital of Chinese People's Armed Police, Shanghai 201103, China
Published: 2026-07-10 doi: 10.13683/j.wph.2026.07.015
Outline
收藏切换

Hyperlipidemia is an important risk factor for cardiovascular and cerebrovascular diseases, and its pathogenesis involves abnormal regulation of multiple key signaling pathways. Traditional Chinese medicine has the advantages of multi-target and multi-pathway in regulating lipid metabolism and improving hyperlipidemia. By intervening in signaling pathways such as adenosine monophosphate activated protein kinase, peroxisome proliferator activated receptor, sterol regulatory element binding protein, liver X receptor, and nuclear factor-κB, it can effectively regulate the synthesis and metabolism of cholesterol and triglycerides. This article reviewed the regulatory mechanisms and experimental research progress of traditional Chinese medicine compound formulas on hyperlipidemia related signaling pathways, providing theoretical basis for clinical applications and new drug development.

hyperlipidemia  /  traditional Chinese medicine formulas  /  signal pathway
李敬超, 陈建军, 贾蔚, 花冠春, 米丽. 中药复方调控高脂血症主要信号通路的研究进展. 世界临床药物, 2026 , 47 (7) : 802 -809 . DOI: 10.13683/j.wph.2026.07.015
Jingchao LI, Jianjun CHEN, Wei JIA, Guanchun HUA, Li MI. Research progress on the regulation of major signaling pathways in hyperlipidemia by traditional Chinese medicine compound formulas[J]. World Clinical Drug, 2026 , 47 (7) : 802 -809 . DOI: 10.13683/j.wph.2026.07.015
Year 2026 volume 47 Issue 7
58
14
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2026.07.015
  • Receive Date:2026-03-31
  • Online Date:2026-11-05
  • Published:2026-07-10
Article Data
Affiliations
History
  • Received:2026-03-31
Funding
Affiliations
    1.Department of Pharmacy, Hainan Corps Hospital of the Chinese People's Armed Police Force, Haikou 202763, Hainan Province, China
    2a.Dean's Office, Shanghai Corps Hospital of Chinese People's Armed Police, Shanghai 201103, China
    2b.Department of Health and Epidemic Prevention, Shanghai Corps Hospital of Chinese People's Armed Police, Shanghai 201103, China
    2c.Department of Pharmacy, Shanghai Corps Hospital of Chinese People's Armed Police, Shanghai 201103, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2026.07.015
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT